MICHELLE COLLINS: Open Payments
NPI 1235235813 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,988 in 137 payments from 15 companies in 2025. Trend: 2023 $1,501 · 2024 $2,531 · 2025 $2,988
Food & beverage: $2,878Education: $109
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $515 |
| Axsome Therapeutics, Inc. | 12 | $387 |
| Teva Pharmaceuticals USA, Inc. | 16 | $372 |
| Janssen Pharmaceuticals, Inc | 10 | $325 |
| ABBVIE INC. | 7 | $240 |
| E.R. Squibb & Sons, L.L.C. | 14 | $227 |
| Alkermes, Inc. | 11 | $191 |
| Otsuka America Pharmaceutical, Inc. | 10 | $189 |
| Collegium Pharmaceutical, Inc. | 6 | $124 |
| Lundbeck LLC | 5 | $106 |
Products named: CAPLYTA, Auvelity, INVEGA SUSTENNA, VRAYLAR, COBENFY, ARISTADA, AUSTEDO XR, REXULTI.
Industry payments across MI — which companies pay providers there.
